About 120 employees are affected, according to Ironwood Pharmaceuticals Inc's latest layoff filing, on January 29, 2025. As of November 14, 2026, Ironwood Pharmaceuticals Inc has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, January 29, 2025).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Ironwood Pharmaceuticals Inc.
Free to see. No signup.
People from Ironwood Pharmaceuticals Inc who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Ironwood Pharmaceuticals Inc layoff? Add yourself to the open-to-work list, free
Your entry
Ironwood Pharmaceuticals Inc reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Ironwood Pharmaceuticals have layoffs in 2025? What its filings say
Ironwood Pharmaceuticals Inc (CIK 1446847) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2025-01-29
Employees affected
This reduction in workforce is expected to be substantially completed by the end of the first half of 2025, following which the Company expects to have approximately 120 full-time employees.
Expected charges
The Company estimates that, in connection with this reduction in its workforce, it will incur aggregate charges of approximately $20.0 million to approximately $25.0 million, primarily comprised of one-time employee severance and benefit costs.
Also on the record for Ironwood Pharmaceuticals Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 10, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 4.1% of the class | 5%+ stakes | Source |
| October 28, 2026 | Stake report, Schedule 13G/A, by BANK OF AMERICA CORP /DE/ | 3.2% of the class | 5%+ stakes | Source |
| October 16, 2026 | Leadership change: Tammi Gaskins appointed, Chief Executive Officer, and 2 more | — | Leadership changes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 8.43% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.4% of the class | 5%+ stakes | Source |
| July 28, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 8.1% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Armistice Capital, LLC | 9.22% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Renaissance Technologies LLC | 4.9% of the class | 5%+ stakes | Source |
| May 13, 2026 | Leadership change: Gregory Martini departs, Chief Financial Officer | — | Leadership changes | Source |
| April 27, 2026 | Stake report, Schedule 13G/A, by BANK OF AMERICA CORP /DE/ | 6.1% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| March 19, 2026 | Stake report, Schedule 13D/A, by Sarissa Capital Management LP | 5.8% of the class | 5%+ stakes | Source |
Keep reading
More on Ironwood Pharmaceuticals Inc and the records around it.
Ironwood Pharmaceuticals Inc elsewhere on the record
- 5%+ stake filings Nov 2026
- Leadership changes Jun 2026
- Who owns it
Companies that share a holder
- Renaissance Technologies LLC also filed stake reports on 48 other companies: Bolt Biotherapeutics, Inc. (Nov 2026), CORE MOLDING TECHNOLOGIES INC (Nov 2026), Hello Group Inc. (Nov 2026)
- BANK OF AMERICA CORP /DE/ also filed stake reports on 74 other companies: BlackRock 2037 Municipal Target Term Trust (Nov 2026), TRIMAS CORP (Nov 2026), PIMCO CALIFORNIA MUNICIPAL INCOME FUND (Nov 2026)
- Barclays PLC also filed stake reports on 116 other companies: BIGLARI HOLDINGS INC-B (Nov 2026), BLUEROCK ACQUISITION CORP II (Nov 2026), CABLE ONE INC (Nov 2026)
Watch Ironwood Pharmaceuticals Inc
Get an email when Ironwood Pharmaceuticals Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Ironwood Pharmaceuticals Inc?
Want the whole picture on Ironwood Pharmaceuticals Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ironwood Pharmaceuticals Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ironwood Pharmaceuticals Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 18 records.
Tools for this story
Each opens in a new tab, filled in for Ironwood Pharmaceuticals Inc. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Ironwood Pharmaceuticals Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/ironwood-pharmaceuticals